研究者業績

武藤 佳恭

タケフジ ヨシヤス  (Takefuji Yoshiyasu)

基本情報

所属
武蔵野大学 データサイエンス学部 教授
学位
工学(慶應義塾)
工学(Keio University)

ORCID ID
 https://orcid.org/0000-0002-1826-742X
J-GLOBAL ID
200901071616096705
researchmap会員ID
5000069498

外部リンク

論文

 774
  • WenKang Huang, Yoshiyasu Takefuji
    Ethics, Medicine and Public Health 2025年  査読有り責任著者
  • Yoshiyasu Takefuji
    Journal of Affective Disorders 2025年1月  査読有り筆頭著者
  • Yoshiyasu Takefuji, Michiyasu Tano, Masaya Shigehara, Shunya Sato
    Computers & Industrial Engineering 2024年12月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Chemico-Biological Interactions 2024年12月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Hygiene and Environmental Health Advances 2024年12月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Materials Circular Economy 2024年12月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Construction Robotics 2024年12月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Journal of Natural Pesticide Research 10 2024年12月  査読有り筆頭著者
    Instructors are always interested in methods to activate learner incentives and motivation to increase learning effectiveness. This paper introduces the Python Package Index (PyPI) as a powerful tool to maximize learner incentives on software and presents an example of its application in agriculture and science. The more useful the PyPI application is, the more it will be downloaded worldwide, providing an external review for the learner, and strengthening their incentive. However, many existing tutorials on PyPI, including the official site, are not updated on the twine library for uploading files to the PyPI site. This paper presents an updated tutorial on using PyPI for counting disaggregated objects such as bugs and pests, and for software reproducibility validation via Code Ocean. Additionally, generative AI is introduced as an indispensable assistant for tasks such as understanding technical terms and providing solutions for encountered problems.
  • Yoshiyasu Takefuji
    Journal of Infection 2024年11月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Atherosclerosis 2024年11月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Cities 2024年11月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Journal of Pediatric Urology 2024年10月  査読有り筆頭著者
  • Y. Takefuji
    Annals of Oncology 2024年10月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Allergo Journal International 2024年9月28日  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Archives of Gerontology and Geriatrics Plus 2024年9月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Archives of Gerontology and Geriatrics 124 2024年9月  査読有り
    This study explores the significant correlation between frailty and an elevated risk of mortality in COVID-19 patients, suggesting that increased frailty screening could enhance disease management and optimize resource distribution. An analysis of peer-reviewed papers on frailty and cardiovascular diseases (CVD) over a ten-year period reveals a peak of 4480 articles from September 2021 to September 2022. The literature review conducted on frailty and CVD highlights the high prevalence of frailty in older adults with CVD and its role as a predictor of cardiovascular death. The study suggests that frailty can inform treatment decisions, offering more personalized care. However, standardizing frailty assessment in clinical practice and trials is needed. The impact of frailty on coronary artery disease, peripheral artery disease, and atrial fibrillation requires further research. The study also discusses the increasing global burden of CVD among older adults due to aging populations and improved care. It highlights the challenges posed by older age, multiple comorbidities, polypharmacy, frailty, and adverse noncardiovascular outcomes. The review focuses on geriatric conditions that significantly impacted health status, quality of life, and overall prognosis. The study concludes that frailty significantly increases the risk of CVD events and major adverse cardiovascular events in older adults without prior CVD. Screening for frailty could help identify those at higher risk and facilitate targeted preventive measures.
  • Yusuke Ichiakwa, Bunpei Sato, Shin-ichi Hirano, Yoshiyasu Takefuji, Fumitake Satoh
    Medical Gas Research 2024年9月  査読有り
  • Yusuke Ichikawa, Bunpei Sato, Shin-ichi Hirano, Yoshiyasu Takefuji, Fumitake Satoh
    Medical Gas Research 2024年9月  査読有り
  • Yusuke Ichikawa, Bunpei Sato, Shin-ichi Hirano, Yoshiyasu Takefuji, Fumitake Satoh
    Medical Gas Research 14(3) 89-95 2024年9月  査読有り
    The Michael J. Fox Foundation has been funding research on Parkinson's disease for 35 years, but has yet to find a cure. This is due to a problem with the philosophy behind the development of modern medical treatments. In this paper, we will introduce "smart medicine" with a substance that can solve all the problems of central nervous system drugs. The substance is the smallest diatomic molecule, the hydrogen molecule. Due to their size, hydrogen molecules can easily penetrate the cell membrane and enter the brain. In the midbrain of Parkinson's disease patients, hydroxyl radicals generated by the Fenton reaction cause a chain reaction of oxidation of dopamine, but hydrogen entering the midbrain can convert the hydroxyl radicals into water molecules and inhibit the oxidation of dopamine. In this paper, we focus on the etiology of neurological diseases, especially Parkinson's disease, and present a case in which hydrogen inhalation improves the symptoms of Parkinson's disease, such as body bending and hand tremor. And we confidently state that if Michael J. Fox encountered "smart medicine" that could be realized with molecular hydrogen, he would not be a "lucky man" but a "super-lucky man."
  • Yoshiyasu Takefuji
    Archives of Gerontology and Geriatrics Plus 2024年8月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Eye 2024年7月28日  査読有り筆頭著者
  • Shin-ichi Hirano, Yoshiyasu Takefuji
    Biomedicines 12(7) 2024年7月17日  査読有り最終著者
    While drug therapy plays a crucial role in cancer treatment, many anticancer drugs, particularly cytotoxic and molecular-targeted drugs, cause severe side effects, which often limit the dosage of these drugs. Efforts have been made to alleviate these side effects by developing derivatives, analogues, and liposome formulations of existing anticancer drugs and by combining anticancer drugs with substances that reduce side effects. However, these approaches have not been sufficiently effective in reducing side effects. Molecular hydrogen (H2) has shown promise in this regard. It directly reduces reactive oxygen species, which have very strong oxidative capacity, and indirectly exerts antioxidant, anti-inflammatory, and anti-apoptotic effects by regulating gene expression. Its clinical application in various diseases has been expanded worldwide. Although H2 has been reported to reduce the side effects of anticancer drugs in animal studies and clinical trials, the underlying molecular mechanisms remain unclear. Our comprehensive literature review revealed that H2 protects against tissue injuries induced by cisplatin, oxaliplatin, doxorubicin, bleomycin, and gefitinib. The underlying mechanisms involve reductions in oxidative stress and inflammation. H2 itself exhibits anticancer activity. Therefore, the combination of H2 and anticancer drugs has the potential to reduce the side effects of anticancer drugs and enhance their anticancer activities. This is an exciting prospect for future cancer treatments.
  • Yoshiyasu Takefuji
    Eye 2024年7月15日  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Archives of Gerontology and Geriatrics Plus 2024年7月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Eye 2024年6月11日  査読有り筆頭著者
  • Yoshiyasu Takefuji
    British Dental Journal 2024年5月24日  査読有り
  • British Dental Journal 236(10) 733-734 2024年5月24日  査読有り筆頭著者
  • Yuki Nakamura, Tsukasa Fukuda, Xuanzhou Yang, Yoshiyasu Takefuji
    Information Security Journal: A Global Perspective 2024年5月23日  査読有り最終著者責任著者
    With the proliferation of the Internet, the number of cyber-attacks has increased worldwide. To prevent cyber-attacks, network administrators need to use analytical tools to disclose six new critical statistics such as Internet Protocol (IP) authenticity and classification, IP ownership, frequency of attacks, time of day, day of the week, and country of attack. There are four SSH attack analysis tools available, but existing tools lack visualization and cannot provide the necessary attack statistics. This paper proposes SSHAA, the first open source PyPI analysis tool that meets the requirement. Text mining technology is used for extracting data from SSH log files, classifying IPs with identified country names and calculating a variety of statistics. PyPI allows SSHAA to run on Windows, MacOS, and Linux operating systems. This paper highlights how to debut a PyPI application using SSHAA which will be the world’s first tutorial in the security journals for maximum software dissemination. According to PePy, SSHAA has been downloaded 7668 times worldwide. The substantial number of downloads signifies the efficacy of the proposed tool. The proposed system offers ten functional statistics for SSH attack analysis. The six new functional statistics to information security are significant.
  • Eye 2024年5月7日  査読有り筆頭著者
  • Journal of Cardiology Cases 2024年5月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    International Immunopharmacology 133 2024年5月  査読有り
    Objective: The study aims to examine the effects of the COVID-19 pandemic on the prevalence of arthritis in the US using a specific generative AI tool. Methods: The AI tool with Bing.com/copilot, designed to generate Python code, uses data from the Centers for Disease Control and Prevention (CDC) to visualize trends and uncover insights in four key areas: (1) The prevalence of arthritis in adults aged 18 years and older who have diabetes, (2) The prevalence of fair or poor health in adults aged 18 years and older who have arthritis, (3) The prevalence of activity limitations due to arthritis in adults aged 18 years and older with doctor-diagnosed arthritis, (4) The prevalence of arthritis in adults aged 18 years and older who are obese. This research did not require approval from an institutional review board or an ethics committee. Results: The findings reveal a significant decline in the prevalence of arthritis among adults with conditions such as diabetes and obesity during the COVID-19 pandemic. There was also an observed improvement in activity limitations among patients with doctor-diagnosed arthritis. Conclusion: The study highlights the potential impact of the pandemic on chronic disease management, particularly arthritis. It underscores the importance of continued monitoring and care for patients with arthritis, especially during a global health crisis like the COVID-19 pandemic. The use of AI tools in generating insights from health data proves to be valuable in this context.
  • Yoshiyasu Takefuji
    British Dental Journal 2024年4月26日  査読有り
  • British Dental Journal 236(8) 582-583 2024年4月26日  査読有り筆頭著者
  • Health and Technology 2024年4月25日  査読有り責任著者
  • Yoshiyasu Takefuji
    Eye 2024年4月18日  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Sexuality and Disability 42(2) 521-526 2024年4月12日  査読有り
    This paper investigates the trends in erectile dysfunction research by integrating individual keywords such as COVID-19, mental health, psychiatry, and drug use. The study spans a six-year period from September 21, 2017, to September 21, 2023, and utilizes resources from the National Library of Medicine. For instance, the quantity of relevant documents is determined using the Google search engine. A custom date range can be set on the browser via tools, and the search is limited to the nih.gov site domain. The phrase-site search command used is executed with “erectile dysfunction” COVID-19 site:nih.gov. The result revealed that from Sept 2021 to 2022, research on COVID-19 and erectile dysfunction spiked. However, the previous year saw a rise in studies linking drugs or mental health with erectile dysfunction. Meanwhile, psychiatry-focused publications have consistently grown. The time-series trends of erectile dysfunction linked to COVID-19 are substantiated by a comprehensive literature review.
  • Yoshiyasu Takefuji
    Archives of Gerontology and Geriatrics Plus 2024年4月  査読有り
  • Yoshiyasu Takefuji
    Journal of Diabetes & Metabolic Disorders 23(1) 1419-1423 2024年3月8日  査読有り
    Objectives: This paper aims to provide a tutorial for diabetologists and endocrinologists on using generative AI to analyze datasets. It is designed to be accessible to those new to generative AI or without programming experience. Methods: The paper presents three examples using a real diabetes dataset. The examples demonstrate binary classification with the ‘Group’ variable, cross-validation analysis, and NT-proBNP regression. Results: The binary classification achieved a prediction accuracy of nearly 0.9. However, the NT-proBNP regression was not successful with this dataset. The calculated R-squared values indicate a poor fit between the predicted model and the raw data. Conclusions: The unsuccessful NT-proBNP regression may be due to insufficient training data or the need for additional determinants. The dataset may be too small or new metrics may be required to accurately predict NT-proBNP regression values. It is crucial for users to verify the generated codes to ensure that they can achieve their desired objectives.
  • Yoshiyasu Takefuji
    Drug Resistance Updates 2024年3月  査読有り
  • Drug Resistance Updates 73 2024年3月  査読有り筆頭著者
  • Yoshiyasu Takefuji
    Archives of Gerontology and Geriatrics Plus 2024年3月  査読有り
  • Shin-ichi Hirano, Yusuke Ichikawa, Bunpei Sato, Yoshiyasu Takefuji, Xiao-Kang Li, Fumitake Satoh
    Advances in Biochemistry in Health and Disease 39-54 2024年2月17日  査読有り
  • Shin-ichi Hirano, Yusuke Ichikawa, Bunpei Sato, Yoshiyasu Takefuji, Xiao-Kang Li, Fumitake Satoh
    Advances in Biochemistry in Health and Disease 2024年  査読有り
  • Yoshiyasu Takefuji
    Journal of Thrombosis and Thrombolysis 2023年12月20日  
  • Yoshiyasu Takefuji
    Journal of Thrombosis and Thrombolysis 57(2) 341-343 2023年12月20日  査読有り
    Through experiencing cardiopulmonary arrest, an artificial intelligence universal biomarker prediction tool was developed to help patients understand improvement in the trends of their disease. PyPI tool handles two biomarkers, hbA1c for diabetes and NP-proBNP for heart failure, to predict the next hospital visit. Predicting improvement in disease is a great hope for patients.
  • Yoshiyasu Takefuji
    Exploratory Research in Clinical and Social Pharmacy 12 2023年12月  査読有り筆頭著者
    The 2022 Medicare Fee-For-Service Improper Payments Report reveals an estimated $80.57 billion in improper payments, with a payment error rate of 15.62%. This paper uses generative AI to analyze and identify which provider types and HCPC codes are most strongly associated with these errors. The paper employs generative AI to produce two Python codes: one generates a time-series trend graph of Medicare improper payments from 2010 to 2022, and the other calculates the number of payment errors by provider type and HCPC code. These codes are designed for novice and non-programmers. Three datasets are used, such as Medicare Fee-for-Service Comprehensive Error Rate Testing dataset released on March 8, 2023, merged codes such as HCPC codes and PCT codes. The result suggests what systems should be improved to reduce Medicare improper payments. Generative AI is being introduced to help novice and non-programmers analyze Medicare improper payments with datasets, aiding researchers in conducting similar tasks in the future.
  • Yoshiyasu Takefuji
    Air Medical Journal 43(3) 262-263 2023年12月  査読有り
    Drawing from a comprehensive Japan-based literature review and the author's personal experience, this article presents findings that highlight potential improvements in clinical outcomes, such as reduced mortality rates, by optimizing the current resuscitation procedure for cardiopulmonary arrest. Many countries have adopted similar procedures for cardiopulmonary arrest. This article presents a prioritized resuscitation method based on scientific evidence, aiming to improve survival rates. The study, which was conducted in Japan, revealed inconsistencies in the current resuscitation procedure for cardiopulmonary arrest. The study did not involve direct participants but relied on literature review for data collection. A literature review was conducted to analyze the survival rates of various resuscitation methods. The interventions reviewed in the literature included cardiopulmonary resuscitation, automated external defibrillator, and automatic mechanical chest compressions. The survival rate of cardiopulmonary arrest in Japan was found to be low. The results of the literature review suggest that cardiopulmonary resuscitation or automatic mechanical chest compressions should be applied before using an automated external defibrillator. The study emphasizes the need to prioritize resuscitation methods with higher survival rates. This article presents a prioritized resuscitation method based on scientific evidence, aiming to improve survival rates. It is hoped that this new approach will lead to a significant improvement in the survival rates of cardiopulmonary arrest patients.
  • Clinical Immunology Communications 4 51-54 2023年12月  査読有り筆頭著者

MISC

 187

書籍等出版物

 41

講演・口頭発表等

 67

担当経験のある科目(授業)

 22

共同研究・競争的資金等の研究課題

 6

社会貢献活動

 21